Novartis supplies Netspot gallium-68 dotatate kits to the Royal Marsden
- The Royal Marsden NHS Foundation Trust
- London
- Direct
- 8 December 2025 to 31 October 2026
The Royal Marsden NHS Foundation Trust bought Netspot (Gallium Ga 68 Dotatate) kits from Novartis Pharmaceuticals UK Limited. The kits supply a diagnostic agent for PET imaging, which the trust needed for its cancer care.
The trust awarded the £316,800 contract to Novartis directly, without a competition. Supply was due to run from December 2025 to October 2026.
- What
- Radiopharmaceuticals and contrast media
- Value
- £316,800
- How it was bought
- Direct
- Dates and next
- Dec 2025 to Oct 2026